The use of interleukin 1 receptor antagonist (anakinra) in Kawasaki disease: A retrospective cases series
Open Access
- 1 August 2018
- journal article
- review article
- Published by Elsevier BV in Autoimmunity Reviews
- Vol. 17 (8), 768-774
- https://doi.org/10.1016/j.autrev.2018.01.024
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart AssociationCirculation, 2017
- Kawasaki disease in adults: Observations in France and literature reviewAutoimmunity Reviews, 2016
- Coronary artery abnormalities in children with systemic-onset juvenile idiopathic arthritisJoint Bone Spine, 2014
- Management of Kawasaki diseaseArchives of Disease in Childhood, 2013
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseasesNature Reviews Drug Discovery, 2012
- Interleukin-1 Is Crucial for the Induction of Coronary Artery Inflammation in a Mouse Model of Kawasaki DiseaseCirculation, 2012
- Effect of race/ethnicity on risk, presentation and course of connective tissue diseases and primary systemic vasculitidesCurrent Opinion in Rheumatology, 2012
- Transcript abundance patterns in Kawasaki disease patients with intravenous immunoglobulin resistanceHuman Immunology, 2010
- Cytokine Genetic Polymorphisms and Susceptibility to Kawasaki Disease in Taiwanese ChildrenCirculation Journal, 2010
- The Treatment of Kawasaki Syndrome with Intravenous Gamma GlobulinNew England Journal of Medicine, 1986